Sobre nosotros
Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible. To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.
- Sitio web
-
https://beonemedicines.com/
Enlace externo para BeiGene
- Sector
- Investigación biotecnológica
- Tamaño de la empresa
- 1 empleado
- Sede
- Cambridge, MA
- Tipo
- Empresa pública
- Fundación
- 2010
- Especialidades
- targeted therapy, immuno-oncology, hematology, oncology y cancer